Physician

David M Dyck, MD

According to 2025 Medicare claims, David Dyck, MD (NPI: 1053303479) practices family practice in the Elkhart-Goshen, IN market, with the plurality of this provider's patient population coming from Elkhart, IN. This provider's primary affiliated billing organization is BEACON MEDICAL GROUP, INC. (NPI: 1639196249; TIN: 351276175) and primary practice location at 46514-7673. Dyck is affiliated with the CHA ACO, LLC (ACO ID: A2207), participating under the MSSP model.

Dyck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 472 traditional Medicare patients, billed 2,894 HCPCS/CPT codes, and received $137,584 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 15,799 prescription claims across 1,185 beneficiaries totaling $1,271,187 in drug costs, led by Ozempic (Semaglutide). DME data shows 228 claims. Open Payments data shows 2 records totaling $93. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and declined steadily, from $28,536 to $20,099.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	601	11,787	$145,333
2016	627	10,032	$148,423
2017	651	4,838	$146,807
2018	582	2,755	$141,301
2019	564	4,639	$133,499
2020	495	2,171	$108,742
2021	552	2,336	$127,066
2022	536	3,812	$126,211
2023	481	2,142	$128,113
2024	472	2,894	$137,584

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	888	15,503	$953,089
2016	890	16,494	$1,017,032
2017	940	16,308	$1,086,520
2018	989	15,507	$1,141,960
2019	971	15,351	$1,118,597
2020	918	15,274	$1,209,925
2021	1,069	15,162	$1,232,246
2022	1,280	15,141	$1,257,519
2023	1,247	15,469	$1,384,380
2024	1,185	15,799	$1,271,187

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	224	865	$28,748
2016	148	760	$21,770
2017	119	566	$12,756
2018	93	677	$20,128
2019	80	568	$12,978
2020	58	374	$13,511
2021	49	217	$9,189
2022	35	207	$7,093
2023	166	392	$1,584,136
2024	28	228	$18,495

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	310	310	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	501	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	239	342	$53
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	326	640	$11
36415	Insertion of needle into vein for collection of blood sample	283	344	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	169	5,900	$181,219
Jardiance	Empagliflozin	137	8,357	$164,060
Mounjaro	Tirzepatide	105	3,108	$114,799
Eliquis	Apixaban	70	3,794	$72,011
Xarelto	Rivaroxaban	63	3,810	$70,750

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	31	$11,692
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	44	$3,092
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	11	$1,709
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	28	70	$1,291
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	13	$310

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$93	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David M. Dyck, MD?

Tedicare shows public-source Medicare data for David M. Dyck, MD (NPI 1053303479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David M. Dyck, MD have ACO affiliation data?

David M. Dyck, MD is shown with ACO affiliation data for CHA ACO, LLC (MSSP, ACO ID A2207).

What billing organization is linked to David M. Dyck, MD?

David M. Dyck, MD is linked to BEACON MEDICAL GROUP, INC. (billing NPI 1639196249) in the available physician profile data.

Does David M. Dyck, MD have Open Payments data?

David M. Dyck, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.